Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

July 07, 2017

GALLAGHER v. OCULAR THERAPEUTIX, INC. et al

Track this case

Case Number:

2:17-cv-05011

Court:

New Jersey

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Susan D. Wigenton

Firms

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 10, 2017

    Investors Sue Eye Drug Co. After Manufacturing Issues

    A potential class of Ocular Therapeutix Inc. investors sued the company in New Jersey federal court Friday, alleging it lied about the quality of its clinical trial-level eye disease drug Dextenza, leading to a stock plunge when manufacturing concerns were made public.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login